General Catalyst Group Management

Latest statistics and disclosures from General Catalyst Group Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by General Catalyst Group Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for General Catalyst Group Management

General Catalyst Group Management holds 12 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Samsara Com Cl A (IOT) 34.5 $63M 2.0M 31.69
 View chart
Arrivent Biopharma (AVBP) 18.8 $35M 1.5M 23.07
 View chart
Maze Therapeatics (MAZE) 16.8 $31M 1.0M 29.85
 View chart
Maplebear (CART) 14.5 $27M 711k 37.46
 View chart
Gitlab Class A Com (GTLB) 10.9 $20M 921k 21.64
 View chart
Eikon Therapeutics 1.8 $3.2M NEW 305k 10.58
 View chart
Fractyl Health (GUTS) 1.2 $2.2M 4.9M 0.46
 View chart
Ethos Technologies Cl A 0.5 $829k NEW 74k 11.17
 View chart
Coupang Cl A (CPNG) 0.4 $693k NEW 37k 18.88
 View chart
Amazon (AMZN) 0.3 $538k NEW 2.6k 208.27
 View chart
Meta Platforms Cl A (META) 0.2 $377k NEW 658.00 572.13
 View chart
Figma Class A Com Stk (FIG) 0.2 $314k 15k 21.14
 View chart

Past Filings by General Catalyst Group Management

SEC 13F filings are viewable for General Catalyst Group Management going back to 2017

View all past filings